We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ABI, Roche, Bio-Rad, and MJ Research Reach Settlement Agreement
News

ABI, Roche, Bio-Rad, and MJ Research Reach Settlement Agreement

ABI, Roche, Bio-Rad, and MJ Research Reach Settlement Agreement
News

ABI, Roche, Bio-Rad, and MJ Research Reach Settlement Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ABI, Roche, Bio-Rad, and MJ Research Reach Settlement Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Applied Biosystems, an Applera Corporation business, and Bio-Rad Laboratories, Inc. have announced that they have entered into a settlement agreement resolving the patent infringement lawsuit originally filed by Applera and Roche Molecular Systems against MJ Research (acquired by Bio-Rad in 2004). The lawsuit was pending in the U.S. District Court for the District of Connecticut.

The settlement also resolves patent infringement claims brought by Applera against Bio-Rad and MJ Research for infringement of Applera's Real-Time thermal cycler instrument patent, filed in November 2004 in the U.S. District Court for the District of Connecticut. Stratagene is now the sole remaining defendant in that lawsuit. 

In connection with the above settlements, Bio-Rad's 1998 thermal cycler supplier license relating to Applera's core thermal cycler patents and Roche's PCR patents has been amended to include the MJ Research thermal cyclers that were subject to the litigation with Applera and Roche.

In addition, Bio-Rad has entered into a license agreement with Applera relating to Bio-Rad's Real-Time thermal cycler instrument business in the United States and Canada, and a limited license in Europe and Japan.

The settlement also resolves litigation brought by Bio-Rad against Applera for patent and trademark infringement in the U.S. District Court for the Northern District of California in 2002, and counterclaims by Applera against Bio-Rad.

As part of the settlement, Applera has entered into a license agreement with Bio-Rad relating to Applera's capillary electrophoresis business.

"We are pleased to have settled these longstanding litigations with Bio-Rad and MJ Research," said Paul D. Grossman, Ph.D., Esq., Vice President, Strategic Planning, Business Development and Intellectual Property at Applied Biosystems.

"Numerous other companies have licensed our patents relating to PCR technology, and we're looking forward to continuing our relationship with Bio-Rad as a licensee of our PCR patent portfolio."

"We are pleased that we have this matter behind us and are looking forward to focusing on supporting our customers," said Bio-Rad Vice President Brad Crutchfield.

Applera Corporation and Roche Molecular Systems originally filed this patent infringement suit in June 1998 against MJ Research relating to certain apparatus and PCR method patents owned by Applera and Roche.

A jury decided in favor of Applera and Roche in April 2004. In September 2005, the Court issued an injunction prohibiting Bio-Rad, as the successor of MJ Research, from manufacturing, selling or servicing the former MJ thermal cycler products in the U.S.

This settlement allows Bio-Rad to resume manufacturing, selling and servicing these products.

Advertisement